Over $98M Raised for Nalu Neurostim System

Image credit: Nalu Medical 

Private neurostim device company, Nalu Medical has this month announced the closing of an equity financing round of almost $AUD99 million ($US65 million).

Led by new investor, Novo Holdings, the company said the financing would support the continued development and commercial growth of its pioneering neurostimulation system, which is designed to treat chronic neuropathic pain.

“The Nalu Team is excited about meaningfully expanding and improving the treatment options in the peripheral nerve pain space by setting a new standard of care while also offering a disruptive, minimally invasive, solution in the established spinal cord stimulation market,” said Nalu Medical President and Chief Executive Officer, Tom West in a press release.

“We continue to invest in building clinical data to expand access for patients who often don’t have other therapeutic options.”

Check out the full press release for further details.